Board of Directors - Independent
Seng Chin Mah, PhD
Seng Chin Mah, PhD
✦ | Chairman, BioVersys AG |
✦
| CEO, Canyon Pharmaceuticals Group AG |
✦
| Executive positions, Novartis |
Alcide Barberis, PhD
Alcide Barberis, PhD
✦ | CEO, Mabylon AG |
✦ | CEO, Humabs Biomed |
✦ | Co-founder, ESBATech AG |
Jin Whan Park
Jin Whan Park
✦
| CEO, JWP & Partners |
✦
| Head of Investment Banking, Yuhwa Securities |
✦ | President, Biomass Korea |
Phil Geon Lee, JD
Phil Geon Lee, JD
✦
| Head of Legal, Korea Investment Corp (KIC) |
| Head of Legal, National Pension Service (NPS) |
| Franklin Templeton Investment Mgmt. |
Joong Myung Cho, PhD
Joong Myung Cho, PhD
| Founder, Chairman and CEO, CrystalGenomics, Inc. |
| Founder, Chairman and CEO, CG Pharmaceuticals, Inc. |
| Executive Senior Managing Director & Director of R&D, LG Chem Biotech Research Institute |
| PhD, University of Houston |
| MS & BS, Seoul National University |
Sang Hyun Kim
Sang Hyun Kim
| Samsung Group (Insurance, Asset Management) |
| Management consultant, Accenture & A.T. Kearney |
| Korean Government (FTA Negotiation Team) |
Hyuk Joo Jee
Hyuk Joo Jee
| Special Advisor, DongKoo Bio Pharma Co., Ltd. |
| COO and Head of Corporate PE, HLB Co., Ltd. |
| Korea Investment Securities (London) |
Team
Peter Hwang 황국현
Chief Executive Officer
Chairman of the Board of Directors
Peter Hwang 황국현
Chief Executive Officer
Chairman of the Board of Directors
| Founder/Managing Partner, Bellevue Capital Management, LLC |
| Korea Representative, Bellevue Asset Management AG |
| Strategic Planning, International Business Development, Shinhan Investment Corp. |
| B.A. in Sociology, Korea University |
Harry Kim 김상훈
Head of Corporate Venture Capital
Harry Kim 김상훈
Head of Corporate Venture Capital
| Managing Director Investment Division, APC Private Equity |
| Division Head of Fixed Income, Alternative Investment, LT Management, Meritz Asset Management |
| Head of Overseas Investment Team, KDB Asset Management |
| University of Minnesota, Twin Cities. LL.M |
Chris Bang 방기현
Chief Financial Officer
Chris Bang 방기현
Chief Financial Officer
| Vice President, Corporate Private Equity Team, COO, Newlake Alliance Management |
| Equity Capital Market Team Head, IPO Department, Risk Management Department, Shinhan Investment Corp. |
| B.A in International Trade, Hansung University |
Tim Smith
Corporate Secretary, Global IR
Tim Smith
Corporate Secretary, Global IR
| Equity Sales Trader, HSBC Securities Seoul |
| Equity Sales Trader, Shinhan Investment Corp |
| Equity Derivatives Trader, Morgan Stanley Seoul |
| BA in Computer Science with Korean language, University of Newcastle |
Constance Höfer, PhD
Chief Scientific Officer, OSR Holdings
Chief Executive Officer, Vaximm
Constance Höfer, PhD
Chief Scientific Officer, OSR Holdings
Chief Executive Officer, Vaximm
| Global Program Head, Merck Healthcare |
| Global Progam Head, Sandoz Biopharma |
| COO, Priaxon AG |
| VP Drug Development, medigene AG |
| Ph.D, Pharmacology, University of Newcastle |
Senyon "Teddy" Choe, PhD
Founder/Chief Executive Officer, Darnatein
Senyon "Teddy" Choe, PhD
Founder/Chief Executive Officer, Darnatein
| Founder, Joint Center for Biosciences |
| Professor & Laboratory Head of Structural Biology, Salk Institue |
| PhD in Biophysics and Medical Physics at Univ. California, Berkeley |
| B.S in Biology, Seoul National University |
ChanKyu Park
Chief Executive Officer, RMC
ChanKyu Park
Chief Executive Officer, RMC
| Hutem |
| MicroVention |
| Boston Scientific Korea |
| Janssen Korea |
Jun Chul Whang, JD
Chief Legal Officer and Director
Jun Chul Whang, JD
Chief Legal Officer and Director
| Partner and General Counsel, Bellevue Capital Management, LLC |
| Partner, Greenspoon Marder (NYC) |
| Partner, Jacob Medinger & Finnegan (NYC) |
| B.A., Dartmouth College |
| J.D., Cornell Law School |
| LL.M., Georgetown University Law Center |
Daeho Kim
Internal Auditor
Daeho Kim
Internal Auditor
| Founder, Stonemountain Advisor, LLC |
| Managing Partner, North Head Capital Partners, LLC |
| Director, Alliance Capital Partners Co., Ltd ("ACPC") |
| VP, SsangYong Investment & Securities |
| MA in Accounting, University of Denver |
Josh Pan, PhD
Venture Partner
Josh Pan, PhD
Venture Partner
| Partner, Bellevue Capital Management, LLC |
| Chief Business Officer, Landmark BioVentures AG |
| Vice President Corporate Development and External Affairs, Athira Pharma |
| Chief Operating Officer, W Fund |
| PhD Molecular and Cellular Biology, University of Washington |
| MBA, University of Washington |
Jessi Kim
Senior Analyst
Jessi Kim
Senior Analyst
| M.D., Chonbuk National University School of Medicine |
| B.S. in Environmental Science, Seoul National University |
Taemin Lee
Analyst
Taemin Lee
Analyst
✦ | B.A. in Business Administration, University of Southern California |
Sein Yang
Analyst
Sein Yang
Analyst
| B.S. in Computer Science and Engineering, Chonnam National University |
OSR Holdings Reg No. 589-86-01485
Email. group@osr-holdings.com
US: 10900 NE 4th Street, 2300 Bellevue, WA 98004
KR: B-dong, 3F, 37-36 Hoedong-gil, Paju-si, Gyeonggi-do
CH: Technologiepark Basel, Hochbergerstrasse 60c
Copyright © OSR Holdings, Inc. All Rights Reserved.
OSR Holdings, Inc. Reg No. 589-86-01485 Email. group@osr-holdings.com
U.S 10900 NE 4th Street, 2300 Bellevue, WA 98004
Korea, Republic of B-dong, 3F, 37-36 Hoedong-gil, Paju-si, Gyeonggi-do
Switzerland Technologiepark Basel, Hochbergerstrasse 60c, CH-4057
Copyright © OSR Holdings, Inc. All Rights Reserved.